Paulson KG, Park SY, Vandeven NA, et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78(3):457-463.e452.

Article  Google Scholar 

van Veenendaal LM, van Akkooi ACJ, Verhoef C, et al. Merkel cell carcinoma: clinical outcome and prognostic factors in 351 patients. J Surg Oncol. 2018;117(8):1768–75.

Article  Google Scholar 

Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma: review. Adv Anat Pathol. 2009;16(3):135–44.

Article  Google Scholar 

Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89(1):1–4.

Article  Google Scholar 

Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832–41.

Article  Google Scholar 

Paulson KG, Lemos BD, Feng B, et al. Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol. 2009;129(6):1547–55.

Article  Google Scholar 

Wong SQ, Waldeck K, Vergara IA, et al. UV-associated mutations underlie the etiology of MCV-negative merkel cell carcinomas. Cancer Res. 2015;75(24):5228–34.

Article  Google Scholar 

Harms PW, Collie AM, Hovelson DH, et al. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation. Mod Pathol. 2016;29(3):240–8.

Article  Google Scholar 

Harms PW, Vats P, Verhaegen ME, et al. The distinctive mutational spectra of polyomavirus-negative merkel cell carcinoma. Cancer Res. 2015;75(18):3720–7.

Article  Google Scholar 

Houben R, Ebert M, Hesbacher S, Kervarrec T, Schrama D. Merkel cell polyomavirus large T antigen is dispensable in G2 and M-phase to promote proliferation of merkel cell carcinoma cells. Viruses. 2020;12(10):1162.

Article  Google Scholar 

Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999;8(2):153–8.

Google Scholar 

Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet. 2002;359(9305):497–8.

Article  Google Scholar 

Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer. 2008;113(9):2549–58.

Article  Google Scholar 

Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100.

Article  Google Scholar 

Houben R, Grimm J, Willmes C, Weinkam R, Becker JC, Schrama D. Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesis. J Invest Dermatol. 2012;132(1):254–6.

Article  Google Scholar 

Houben R, Shuda M, Weinkam R, et al. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol. 2010;84(14):7064–72.

Article  Google Scholar 

Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol. 2009;129(1):246–8.

Article  Google Scholar 

Kassem A, Schopflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 2008;68(13):5009–13.

Article  Google Scholar 

Becker JC, Stang A, Hausen AZ, et al. Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunol Immunother. 2018;67(3):341–51.

Article  Google Scholar 

Becker JC, Houben R, Ugurel S, Trefzer U, Pfohler C, Schrama D. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol. 2009;129(1):248–50.

Article  Google Scholar 

Laude HC, Jonchere B, Maubec E, et al. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog. 2010;6(8):e1001076.

Article  Google Scholar 

Paulson KG, Carter JJ, Johnson LG, et al. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res. 2010;70(21):8388–97.

Article  Google Scholar 

Paulson KG, Lewis CW, Redman MW, et al. Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study. Cancer. 2017;123(8):1464–74.

Article  Google Scholar 

Arroyave AJ, Lewis JM, Landry M, McLoughlin JM, Enomoto LM. Merkel cell polyomavirus antibody titer predicts recurrence-free survival. Ann Surg Oncol. 2022;29(3):1620–6.

Article  Google Scholar 

Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009;5(9):e1000578.

Article  Google Scholar 

Touze A, Gaitan J, Arnold F, et al. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol. 2010;48(5):1767–70.

Article  Google Scholar 

Touze A, Le Bidre E, Laude H, et al. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J Clin Oncol. 2011;29(12):1612–9.

Article  Google Scholar 

Yang JF, Liu W, You J. Characterization of molecular mechanisms driving Merkel cell polyomavirus oncogene transcription and tumorigenic potential. PLoS Pathog. 2023;19(8):e1011598.

Article  Google Scholar 

Houben R, Celikdemir B, Kervarrec T, Schrama D. Merkel cell polyomavirus: infection, genome, transcripts and its role in development of Merkel cell carcinoma. Cancers (Basel). 2023;15(2):444.

Article  Google Scholar 

Starrett GJ, Marcelus C, Cantalupo PG, et al. Merkel cell polyomavirus exhibits dominant control of the tumor genome and transcriptome in virus-associated merkel cell carcinoma. mBio. 2017. https://doi.org/10.1128/mBio.02079-16.

Article  Google Scholar 

Goh G, Walradt T, Markarov V, et al. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget. 2016;7(3):3403–15.

Article  Google Scholar 

Sunshine JC, Jahchan NS, Sage J, Choi J. Are there multiple cells of origin of Merkel cell carcinoma? Oncogene. 2018;37(11):1409–16.

Article  Google Scholar 

Liu W, Yang R, Payne AS, et al. Identifying the target cells and mechanisms of Merkel cell polyomavirus infection. Cell Host Microbe. 2016;19(6):775–87.

Article  Google Scholar 

Nirenberg A, Steinman H, Dixon J, Dixon A. Merkel cell carcinoma update: the case for two tumours. J Eur Acad Dermatol Venereol. 2020;34(7):1425–31.

Article  Google Scholar 

Gravemeyer J, Spassova I, Verhaegen ME, et al. DNA-methylation patterns imply a common cellular origin of virus- and UV-associated Merkel cell carcinoma. Oncogene. 2022;41(1):37–45.

Article  Google Scholar 

Wijaya WA, Liu Y, Qing Y, Li Z. Prevalence of merkel cell polyomavirus in normal and lesional skin: a systematic review and meta-analysis. Front Oncol. 2022;12:868781.

Article  Google Scholar